Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 5, 2014, Pages 1102-1108

  Zhu, Chengzhan ^a   Ikemoto, Tetsuya ^a   Utsunomiya, Tohru ^a   Yamada, Shinichiro ^a   Morine, Yuji ^a   Imura, Satoru ^a   Arakawa, Yusuke ^a   Takasu, Chie ^a   Ishikawa, Daichi ^a   Shimada, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

HGF; Liver regeneration; Met; P16; Senescence

Indexed keywords

CALCIUM BINDING PROTEIN; PROTEIN P16; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SIRTUIN 1; SMP30 PROTEIN; UNCLASSIFIED DRUG; MET PROTEIN, HUMAN; P16 PROTEIN, HUMAN; RGN PROTEIN, HUMAN; SIGNAL PEPTIDE; SIRT1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; AGING; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CLINICAL ASSESSMENT; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LIVER WEIGHT; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURGICAL PATIENT; DOWN REGULATION; GENETICS; METABOLISM; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; CALCIUM-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1; UP-REGULATION;

EID: 84898913979     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12468     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69-90.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 2006; 45: 529-538.
3. Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J. Clin. 2011; 61: 113-132.
4. Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J. Surg. 2012; 36: 1102-1111.
5. Iakova P, Awad SS, Timchenko NA. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003; 113: 495-506.
6. Timchenko NA. Aging and liver regeneration. Trends Endocrinol. Metab. 2009; 20: 171-176.
7. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-53.
8. Sawada N. Hepatocytes from old rats retain responsiveness of c-myc expression to EGF in primary culture but do not enter S phase. Exp. Cell Res. 1989; 181: 584-588.
9. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res. 2007; 35: 7417-7428.
10. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech. Ageing Dev. 2008; 129: 467-474.
11. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130: 223-233.
12. Langley E, Pearson M, Faretta M etal. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 2002; 21: 2383-2396.
13. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell. Cardiol. 2007; 43: 571-579.
14. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim. Biophys. Acta 1992; 1116: 122-128.
15. Indovina P, Marcelli E, Casini N, Rizzo V, Giordano A. Emerging roles of RB family: new defense mechanisms against tumor progression. J. Cell. Physiol. 2013; 228: 525-535.
16. Reinhardt HC, Schumacher B. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet. 2012; 28: 128-136.
17. Yamashiki N, Sugawara Y, Tamura S etal. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transpl. 2006; 12: 1077-1083.
18. Hanaoka J, Shimada M, Uchiyama H etal. A simple formula to calculate the liver drainage volume of the accessory right hepatic vein using its diameter alone. Surgery 2009; 146: 264-268.
19. Hahn WC, Weinberg RA. Rules for making human tumor cells. N. Engl. J. Med. 2002; 347: 1593-1603.
20. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265-275.
21. Collado M, Gil J, Efeyan A etal. Tumour biology: senescence in premalignant tumours. Nature 2005; 436: 642.
22. Kang TW, Yevsa T, Woller N etal. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-551.
23. Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int. J. Cancer 2012; 130: 1715-1725.
24. Baker DJ, Wijshake T, Tchkonia T etal. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-236.
25. Hoshida Y, Villanueva A, Kobayashi M etal. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 2008; 359: 1995-2004.
26. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc. Natl Acad. Sci. U.S.A. 2004; 101: 10608-10613.
27. Sanada F, Taniyama Y, Azuma J etal. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 2009; 53: 77-82.
28. Jin J, Iakova P, Jiang Y, Medrano EE, Timchenko NA. The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology 2011; 54: 989-998.
29. Ishigami T, Fujita T, Simbula G etal. Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes. Pathol. Int. 2001; 51: 491-497.
30. Lin TY, Lee CS, Chen CC, Liau KY, Lin WS. Regeneration of human liver after hepatic lobectomy studied by repeated liver scanning and repeated needle biopsy. Ann. Surg. 1979; 190: 48-53.
31. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann. Surg. 1987; 206: 30-39.
32. Yamanaka N, Okamoto E, Kawamura E etal. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993; 18: 79-85.